TIMING MATTERS. “Early clinical trials have suggested significant clinical benefits of specific circadian timing of chemotherapy or radiotherapy by combination with vinblastine, cyclophosphamide, and methotrexate or 5-fluorouracil.”
https://lnkd.in/dT2NKaY
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022